各イベント詳細
イベント一覧へ戻る

PMDA's Recent Challenges -Regulatory Science and Innovation

18 Oct 2018
Information for our guests:

Date Thu, 18-Oct-2018
Start 12:00
End 14:00
Venue Tokyo American Club
Hall/ Room Manhattan 2
Address 2-1-2, Azabudai, Minato-ku, Tokyo 106-8649
Venue Reference Map URL
Guests Fee (Yen) 7,900
Committees Healthcare. Pharmaceuticals. Medical Devices and Diagnostics. Digital Health. Regenerative Medicine and Biosciences.
Speaker(s) Dr. Tatsuya Kondo (Chief Executive Pharmaceuticals and Medical Devices Agency (PMDA)).
Registration Deadline Mon, 15-Oct-2018 12:00

Information source: http://www.accj.or.jp/accj-events

In recent years, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has taken several steps towards innovating the regulatory process to deliver safer and more effective medicines and devices to patients. Dr.Tatsuya Kondo, Chief Executive of PMDA will provide a comprehensive presentation on the PMDA's recent challenges.

PMDA has implemented various innovative regulatory initiatives including SAKIGAKE Designation System, Conditional Early Approval System for Pharmaceuticals and MID-NET project. And most recently, PMDA has established Regulatory Science Center which is the command center of PMDA’s Regulatory Science. PMDA also gives high priority on international cooperation and continue its efforts for patients in the world together with other regulatory authorities.

Dr. Kondo's presentation promises to provide healthcare company representatives with a rare opportunity not only to learn about the future course of regulatory reviews and approvals in Japan, but also to directly converse with one of Japan's key healthcare leaders on Japan's plans for its healthcare industry. If your business is in healthcare or related to the healthcare industry, you will not want to miss this unique opportunity.
イベント一覧へ戻る
[メインページへ]
Copyright(C) MedicaLingual Inc. All Rights Reserved.
本サイトの文章・画像の無断転用、転写はご遠慮下さい。